Strong accumulation continues. The float is drying up. Anyone who wants in for the long term upside had better buy soon or they'll be paying several times the current price in a few weeks.
Each of the new board members have over 500 connections on Linkedin. Please note who were some of the recent viewers of their profiles.
Each is a potential new shareholder. The word is getting out to the market.
There are some very prominent individuals viewing their profiles. Take the time to view these individual's profiles. I would bet they're within six degrees of every C.E.O. of every major drug company in the world.
Dr. Adam J. Simon
• Jim Ray
Senior Director at Envoy Therapeutics,...
• Joseph Vacca
Head of Early Success Sharing...
• David Devilbiss
Founder of NexStepBiomarkers, LLC.
• Paul Shughrue
Research at Prothena Biosciences
• Mary J. Savage
Scientific Director at Merck and Company
• Sethu Sankaranarayanan
Scientist at Bristol-Myers Squibb
• Jeffrey Vivian
• Peter Como
Neuropsychologist at Food and Drug...
• Annie Liang
Research Biologist at Merck